News Releases
June 28 , 2010
Ikano Therapeutics in Exclusive Global Licensing Agreement for ITI-111 (Nasal Midazolam). VIEW PDF
November 9 , 2009
Ikano Therapeutics Receives Orphan Drug Designation for Epilepsy Drug. VIEW PDF
March 2 , 2009
ITI Announces Name Change and Update in Funding. VIEW PDF
December 8 , 2008
ITI Announces New Progress Milestones in its Development Program for Acute Repetitive Seizure in Epilepsy. VIEW PDF
